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n a world whose population exceeds 6.5 billion, declining human fertility might
not seem to be a critical problem. After all, overpopulation has been a global
concern for decades. Declining fertility rates in more advanced nations largely reflect
the changing role of women and their rapidly growing presence in the workplace—
fertility declines may stem at least in part from the modern tendency to delay child-
bearing until later in life, when fertility naturally declines. But this doesn’t explain the
fact that, according to a December 2005 report of the CDC’s National Survey on
Family Growth (NSFG), the fastest-growing segment of U.S. women with impaired
fecundity (the capacity to conceive and carry a child to term) is those under 25. The
rising incidence of fertility-impairing health factors such as obesity also likely plays anS
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important role. Clues from environmental
exposure assessments, wildlife studies, and
animal and human studies hint at additional
factors: exposure to low-level environmental
contaminants such as phthalates, polychlori-
nated biphenyls (PCBs), dioxins, pesticides,
and other chemicals may be subtly under-
mining our ability to reproduce.
As recognized by the American Society of
Reproductive Medicine, infertility is a bio-
logical disease that impairs a couple’s ability
to achieve a viable pregnancy. It can be
caused by hormonal, ovarian, uterine, uro-
logical, and other medical factors. Known
risk factors include advanced age, being over-
or underweight, lack of exercise, smoking,
alcohol and substance abuse, sexually trans-
mitted diseases, and poor nutrition. 
According to the American Society of
Reproductive Medicine, a medical infertility
cause can be identified, or perhaps only
indefinitely suggested, in approximately
90% of cases and may be multifactorial in
25% of cases. Male factors include low
sperm count and sperm abnormalities, such
as altered morphology and low motility.
Female factors stem from ovulation prob-
lems such as premature ovarian failure (early
menopause), thyroid irregularities, polycystic
ovarian syndrome, and fallopian tube
obstruction.
Up to 10% of infertility cannot be
explained medically. Fertility transcends the
reproductive system, notes Louis Guillette, a
professor of zoology at the University of
Florida in Gainesville. “When you talk about
infertility, you literally are talking about
probably almost every system in the body—
infertility is an integrated signal of all these
different systems,” he explains. “Trying to
tease out which system, or more than likely
what multiple systems have been altered,
leading to that phenomenon, is very
tough work.”
Infertility is generally
defined as occurring when
a couple cannot be-
come pregnant after
trying to conceive
for at least one year
(or six months if the
woman is over age 35).
According to the 2001
WHO report Current Prac-
tices and Controversies in Assisted
Reproduction, at least 80 million peo-
ple worldwide are estimated to be affected by
infertility. Infertility rates range from less
than 5% to greater than 30% depending on
location and how infertility is defined, with
higher rates associated with lack of medical
care access. Based on the 2005 NSFG report,
approximately 12% of American couples
experienced impaired fecundity in 2002.
This is a 20% increase from the 6.1 million
couples who reported an inability to have
children in 1995. 
Determining whether infertility is actual-
ly increasing is more complicated than these
numbers imply, however. In a paper pub-
lished in the September 2006 issue of
Fertility and Sterility, David Guzick and
Shanna Swan of the University of Rochester
School of Medicine and Dentistry noted that
“impaired fecundity” as defined by the
NSFG implies a decrease in fertility, but the
same study also showed that fertility, defined
there as a married woman unable to become
pregnant within 12 months, has increased.
The absence of definitive information
can frustrate couples experiencing fertility
problems as well as experts. “There seems to
be more to it than can be explained from tra-
ditional understanding about impacts,” says
Joseph Isaacs, president and CEO of
RESOLVE: The National Infertility Associ-
ation. “As a patient advocacy group, we
believe more research into environmental
impacts is needed. We fear that future gener-
ations may be at risk because of exposures to
toxic substances as early as in utero.” 
Foundations of Fertility
A person’s reproductive potential begins
shortly after his or her own conception.
Based on the embryo’s chromosomal inher-
itance, hormonal signals are created to
direct the structure and function of the
reproductive tract. Normal development
depends upon a correct balance of andro-
gen and estrogen signals being delivered at
appropriate times. 
Fetal development can be altered by
external factors as demonstrated by the
human experience with the synthetic estro-
gen diethylstilbestrol (DES), prescribed to
prevent miscarriage between 1947 and 1971.
The drug didn’t affect mothers, and it didn’t
lower miscarriage incidence; in fact, it signif-
icantly increased it. It also induced changes
in the developing reproductive tract of
female offspring. 
In the 15 April 1971 issue of the New
England Journal of Medicine, it was reported
that daughters with prenatal DES exposure
had significantly increased incidence of
vaginal cancer, which is normally quite rare
and was virtually unknown in young
women prior to DES. Later research
revealed structural abnormalities of these
women’s reproductive tracts and effects in
their male offspring including increased risk
of cryptorchidism (undescended testes) and
low sperm counts.
The study of endocrine disruptors has
raised concerns about the reproductive
effects of exposure to certain environmental
compounds that affect the endocrine sys-
tem via estrogenic, androgenic, antiandro-
genic, and antithyroid mechanisms. One
key report was a 12 September 1992 review
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Her side. Female factors in infertility stem
from ovulation problems,thyroid irregularities,
polycystic ovarian syndrome, and fallopian
tube obstruction. A trend among women to
delay starting a family also has impacted
fertility rates.Environmental Health Perspectives • VOLUME 114 | NUMBER 11 | November 2006 A 647
in the British Medical Journal indicating
significant declines in sperm counts in
many countries between 1938 and 1990.
The findings were controversial because the
reviewed studies used inconsistent designs
and methods. In October 1997, however, a
review published in EHP by Swan and oth-
ers confirmed the findings for males in the
United States and indicated an even sharp-
er decline among European men. Other
studies have found declines for specific
areas or no decline at all. 
“I think the evidence across studies is
mixed,” says Russ Hauser, an associate pro-
fessor of environmental and occupational
epidemiology at Harvard School of Public
Health. “Historical studies were not
designed to explore this question. It wasn’t
that someone set out forty or fifty years ago
to design a study to look at how semen
quality is going to change over time.” There
are going to be limitations in the data
because of that, he explains, so it’s hard to
determine whether there is a true temporal
trend. “However,” he adds, “the data sug-
gest there are definite geographical differ-
ences between countries and regions within
countries in semen quality.” 
According to Niels Skakkebæk of
Rigshospitalet in Copenhagen and colleagues
writing in the February 2006 issue of the
International Journal of Andrology,  compar-
isons of sperm quality among populations of
European men have revealed that as many as
30% of young Danish men have low sperm
count, and an additional 10% may be infer-
tile. Denmark also has an unusually high rate
of testicular cancer. Rates have been increas-
ing in many countries over the last 50 years,
but the Danish rate is noticeably higher; for
example, four to five times higher than the
Finnish rate. 
This difference prompted researchers to
also examine incidence of hypospadias (in
which the urethra opens along the underside
of the penis shaft rather than the tip) and
cryptorchidism. Not only did both disorders
occur more frequently in Danish boys com-
pared with Finnish boys, but the Danish
rates had risen in recent decades. These
findings as a whole inspired Skakkebæk and
colleagues to propose, in the May 2001 issue
of Human Reproduction, an overarching dis-
order, testicular dysgenesis syndrome (TDS),
in which perturbation of testis development
in fetal life sets the stage for hypospadias,
cryptorchidism, testicular cancer, and
reduced sperm quality. 
It’s reasonable to suspect there might be
a female corollary to TDS. “We have no
really good reasons not to expect that
women are as sensitive to environmental
chemicals as the males are,” says Jens Peter
Bonde, a professor of occupational medi-
cine at Århus University Hospital in
Copenhagen. He points out that it’s easier
to study male fertility because men can eas-
ily provide sperm samples. “That’s one
basic reason that there has been so much
attention on the males, but from a biologi-
cal point of view one would definitely
expect that the female reproductive system
might be vulnerable also,” says Bonde. 
According to Guillette, another stum-
bling block is the accepted, but unproven,
dogma that an embryo will develop
as a normal female barring any
hormonal signals to become
male. “It hasn’t been an
area where there have
been substantial
amounts of work
done. There’s cer-
tainly very good
work, but not the
same kind of huge body
of literature that one sees
about the developing testis and
the male reproductive system,” he
says. 
One of the few epidemiologic studies to
link low-level human exposure to an envi-
ronmental contaminant with a specific end
point was Swan and colleagues’ investigation
of prenatal phthalate exposure, published in
the August 2005 issue of EHP. Their results
suggested a subtle change in boys’ develop-
ment—a shortening of the anogenital index
(the distance between the anus and the scro-
tum, divided by weight)—associated with
prenatal exposure to several phthalates. This
finding is not a predictor of future fertility
and needs confirmation, but it is noteworthy
as the first study to link verified prenatal
exposure to a specific outcome.
Animal Findings to Human
Concerns?
Consequences of disrupting the normal hor-
mone milieu have also been observed in
wildlife. Examining alligators in polluted
lakes in northern Florida, Guillette’s group
has observed altered function of the ovaries
and testes, smaller penis size, and abnormal-
ities that extend to the thyroid gland, liver,
and immune system. A robust body of liter-
ature details reproductive effects in fish,
amphibians, and reptiles related to their
exposure to endocrine disruptors. Evidence
of these effects has also been seen in wild
mammals such as polar bears and seals.
Laboratory animal experiments have con-
firmed these wildlife findings, demonstrating
that effects are not necessarily from steroid
receptor disruption, however, but may, for
example, be observed in altered synthesis and
control of endogenous hormones.
The study of fertility also encompasses
pregnancy, especially the early weeks fol-
lowing fertilization. Early pregnancy loss is
normally quite high in humans, with an
estimated 30% of pregnancies ending in
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His side. Male infertility can arise from
factors such as low sperm count and sperm
abnormalities including altered morphology
and low motility. Up to 10% of infertility
cannot be explained medically.miscarriage in the first six weeks. A frequent
cause of miscarriage is aneuploidy, an
incorrect number of chromosomes in the
embryo, and mouse studies have shed some
light on potential environmental contribu-
tors to this condition. 
During a 1998 investigation of age-
related aneuploidy rate increases, Patricia
Hunt, a professor of molecular biosciences
and a reproductive biologist at Washington
State University, and her colleagues were
amazed to see a sudden rate spike in their
mouse colony. An investigation revealed
correlation between damage to the plastic
mouse cages and the chromosomal abnor-
mality. Further scrutiny implicated bisphe-
nol A (BPA), a suspected environmental
estrogen used in plastics manufacture, as
the potential causal agent. In a study pub-
lished in the 1 April 2003 issue of Current
Biology, the researchers replicated exposure
experimentally and found that BPA de-
railed proper chromosome segregation dur-
ing oocyte meiosis. 
An extension of this research has been
completed with amazing—but not yet pub-
lished—results, and Hunt hopes that the
line of inquiry can be extended to humans.
“One of the things that my new research on
BPA has made me wonder is whether or not
there could be environmental effects that
would change the frequency or in specific
populations might cause noticeable differ-
ences in aneuploidy,” she says.
Hunt says it’s hard to know precise num-
bers of human aneuploidy cases. “We can’t
see the loss that occurs preimplantation, but
we make an assumption that there’s quite a
bit, based on what we can see and what we
think must happen,” she says. But whether
there’s been an increase in aneuploidy over
time cannot be known. “Human aneuploidy
studies were done mostly in the 1970s and
early 1980s,” says Hunt. “Is this aneuploidy
rate the same across all populations? To the
best of our knowledge, it has been, at least in
those previous studies. But is the rate the
same as it was then? We wouldn’t know. We
wouldn’t be able to see a dramatic increase in
chromosomally abnormal spontaneous abor-
tions, because those kinds of studies aren’t
currently under way.”
Extending animal studies to human
health is a challenge, though. Genetically, the
reproductive system is highly conserved
across species, making it likely that responses
to inputs would be similar. But species dif-
ferences in exposure, metabolism, and anato-
my preclude making a direct comparison. 
“Wildlife studies cannot be related to
humans one to one,” says Guillette. “If
one’s looking at the functioning of
the ovary, or the functioning
of the brain, and hor-
mones, and even the
genes that seem to be
involved with the
proliferation or the
growth of the uterus or the
development of an egg, for
example, they’re incredibly con-
served.” He explains that if problems are
seen in these animals at a certain level, and
researchers are able to identify mechanisms
that are being disturbed leading to those
abnormalities, then that raises possible con-
cerns for humans, even if humans are
exposed in a slightly different manner.
Worldwide Concerns
Geographic differences may suggest environ-
mental exposures that need investigation,
wrote Swan in a paper published in the
February 2006 issue of Seminars in Repro-
ductive Medicine. For example, in the first
phase of the EPA-funded Study for Future
Families, of` which Swan is the principal
investigator, she and her colleagues saw sig-
nificant reductions in sperm concentration,
motility, and total motile sperm in men from
Columbia, Missouri, compared with men in
New York City, Minneapolis, and Los An-
geles. In an in-depth follow-up study com-
paring variables between the Columbia and
Minneapolis men, the researcher discovered
that the Missouri group had had higher
exposure to agricultural pesticides. Further,
men with low sperm counts were more like-
ly to have higher urine metabolite levels of
the pesticides alachlor, atrazine, metolachlor,
and diazinon.
Another geographically based study,
INUENDO, investigates risks to human
fertility from persistent environmental
organochlorines. The European Commis-
sion project centers on Arctic populations
including Swedish fishermen and the Inuit
of North America and Greenland, whose
exposure to persistent organic pollutants
such as PCBs and DDT metabolites are
among the highest in the world. “There are
many indications from animal studies and
from wildlife studies, but very few indica-
tions from human studies telling us whether
we have a problem or not,” says Bonde, who
serves as coordinator of INUENDO. 
“The basic idea [behind INUENDO]
was to go to places in the world where we
know that people have high level of expo-
sures to substances that are suspected to
cause these effects in fertility,” says Bonde.
“That’s the reason we went to Greenland
and to Sweden, where fishermen are known
to have very high exposure levels; we have
other populations that have lower levels of
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The wild side. Animal and wildlife studies
of reproductive health effects, including
mouse aneuploidy data, may help inform
knowledge of human effects. Although the
reproductive system is highly conserved
across species, differences in exposure,
metabolism, and anatomy make direct inter-
species comparisons impossible.Environmental Health Perspectives • VOLUME 114 | NUMBER 11 | November 2006 A 649
exposures, so we have contrasts of expo-
sure.” Results published in March 2006 in
Human Reproduction suggested a longer
time to pregnancy related to serum concen-
trations of PCB and DDE in mothers and
fathers. Additional results published in the
May 2006 EHP suggested an altered sex
ratio of offspring (fewer boys than would
otherwise be expected) related to PCB and
DDE exposures.
Exploring multicompound exposures is
yet another challenge in environmental epi-
demiology. “Individuals are exposed to many
different phthalates, a variety of persistent
and nonpersistent pesticides, different pat-
terns of PCB congeners, as well as other
chemicals,” says Hauser. “How do we take all
that information, based on the chemical
assessment in urine or in blood, and use that
to assign exposure for that individual to ten,
or twelve, or many more different com-
pounds?” he says. In the April 2006 issue of
EHP, Hauser’s group described evidence sug-
gesting a relationship between PCBs and
phthalates and human sperm motility, possi-
bly due to PCBs’ inhibiting a key enzyme in
phthalate metabolism.
Genes themselves offer another platform
for investigation. Hugh Taylor, director of
the Yale Center for Research in Reproductive
Biology, leads a team investigating the role of
estrogen-regulated  Hox genes that direct
uterine development. The researchers initial-
ly focused on DES effects and discovered
that the compound alters expression of the
Hoxa10 gene in mice, affecting the tissue
type that grows in the uterus, cervix, and
vagina. Effects were triggered only with
exposure during development, but not dur-
ing adulthood, and later experiments
revealed that the pesticide methoxychlor had
similar effects. 
“The important thing is that these agents
really seem to imprint the expression pattern,
even long after the agent is removed or there’s
no longer an exposure,” says Taylor. “When
we have a clear-cut animal model and know
the genes that are affected, we can start to
think about evaluating that exposure by
looking for changes in the gene expression
earlier and see if it has a significant effect
rather than waiting a whole generation.”
This is a goal of research in epigenetics,
the study of how genetic messages may be
edited through methylation or other means
without changing the actual DNA sequence.
For example, Rebecca Sokol and colleagues at
the University of Southern California are cur-
rently investigating whether DNA methy-
lation in sperm might serve as a bio-
marker of environmental expo-
sure and a means of assess-
ing male fertility. Addit-
ionally, preliminary
work at Washington
State University
and at the NIEHS
indicates that an epi-
genetic event in one
generation can “repro-
gram” the germline and
affect later generations. In
essence, the exposures of one’s great-
grandparents could still matter today.
Expanding Understanding
Previous generations’ exposures would be
useful information to have, according to
Hunt. “What we really need is data on gen-
erations ago, and we simply don’t have that
data,” she says. “We have to wait a generation
to see. We have to wait until . . . young
exposed males grow up to the point where
we can assess sperm counts.” 
This will require prospective studies to
determine early exposures. “If you want to
look at fertility—and it’s difficult to do—you
ideally would want to do a study in which
you start assessing environmental exposures
preconception,” says Hauser. “You’d have to
identify couples who are thinking of trying
to conceive and try to understand their envi-
ronmental exposures, and then follow them
forward in time.” 
According to Alison Carlson, a senior fel-
low at The Collaborative on Health and the
Environment (CHE) in Bolinas, California,
another need is very basic: tracking the inci-
dences of infertility and common known
causes. “For us to try to make headway
studying environmental influences on fertili-
ty, it’s really hard when we don’t have good
baseline data,” she says. “We don’t know the
real incidence and prevalence rates of prema-
ture ovarian failure and polycystic ovarian
syndrome and lots of other end points that
people study. We don’t know what they are,
so how can we study trends and the environ-
mental contributions?” she asks. 
A thorough exploration of environmental
effects on fertility will require the expertise of
demographers, epidemiologists, clinicians,
biologists, wildlife researchers, geneticists,
molecular biologists, exposure assessment
specialists, toxicologists, and others—and
discussion requires someone “to set the
table,” says Carlson. A February 2005 work-
shop titled “Understanding Environmental
Contaminants and Human Fertility Com-
promise: Science and Strategy” demonstrated
multidisciplinary fervor for investigation,
and a more in-depth conference, the “Sum-
mit on Environmental Challenges to Repro-
ductive Health and Fertility,” cosponsored by
CHE and the University of California, San
Francisco, is scheduled for 28–30 January
2007. “Reproduction is such a human, deep-
seated, deeply psychically coded thing,” says
Carlson. “It’s hard not to care about fertility
compromise.”
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A view inside. Understanding that a person’s
reproductive health can be linked to the very
earliest of exposures, possibly even paternal or
maternal exposures prior to conception, points
up the critical need to elucidate the health
effects of environmental chemicals. 